Skip to main content
Editorial31 December 2024
Editorial: Optimal omegas

Trends towards sustainable plant-based diets mean that modern dietary staples are shifting with momentum, leading to ramifications for intakes of omega-3 fatty acids and the essential fatty acid metabolic pathway. Subsequently, there are growing demands for sustainable food-derived sources of omega-3 (ω-3) fatty acids.Two publications in the special edition used National Health and Nutrition Examination Survey (NHANES) data. Li et al. (2024) identified that omega-3 and omega-6 polyunsaturated fatty acids were negatively associated with neutrophil-lymphocyte ratio, white blood cell counts, systemic immune-inflammation index and platelet-lymphocyte ratio. Interestingly, Yan et al. (2024) found that omega-3 intakes exceeding 2.05 grams and ω-6 intakes ranging from more than 11.42 grams to less than or equal to 19.16 grams lowered frailty risk amongst middle-aged and elderly individuals.An updated systematic review of randomized controlled trials found that eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) both lower triglyceride levels, with docosahexaenoic acid having a greater effect (Choi & Calder, 2024). Li et al. (2024) found that mussel oil was more potent than fish oil in preventing atherosclerosis, with the downregulation of p38MAPK/NF-κB signalling pathway being one plausible mechanism. Derbyshire et al. (2024) discussed potential ways forward focusing on innovative delivery methods to utilize omega-3 long-chain polyunsaturated fatty acid rich oils including the use of fortification strategies, bioengineered plants, microencapsulation, and microalgae.A pilot study in patients with the homozygous ancestral (minor) FADS1 genotype demonstrated that FADS1 genotypes significantly decreased blood levels of ω-6 polyunsaturated fatty acids (PUFAs), particularly arachidonic acid (AA) without having a notable impact on the ω-3 PUFAs such as EPA and DHA, liver fat content and AA-derived lipid mediators (Rebehl et al., 2024). Macura et al. (2024) found the resilience of DHA homeostasis in the retina and retinal pigmented epithelium (RPE) of 2-month-old mouse offspring, even following high-dose fish oil supplementation during pregnancy and lactation. Another significant finding in this study was an upregulation of major facilitator superfamily domain-containing protein (Mfsd2a), a key DHA transporter and transcytosis regulator during development. The post-market cohort study showed that AlmegaPL®, an EPA-only polar lipid supplement derived from the microalga Nannochloropsis, effectively reduced triglycerides (TG) and remnant cholesterol (RC) in a real-world consumer setting (Ganuza et al., 2024).A clinical trial conducted by Rafieipoor et al. (2024) revealed that ω-3 supplementation (3 g/day for 2 months) did not have a significant effect on managing chronic kidney diseaseassociated pruritus (CKD-aP) in patients undergoing hemodialysis.Overall, these articles have provided some valuable field insights within the omega scientific field. In particular, non-animal derived sources of omegas is an exciting area to monitor for the future and one for which ongoing research is highly valuable. https://www.frontiersin.org/research-topics/55848/optimal-omegas/articles

1,856 views

1 citations

The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors: an updated systematic review of randomized controlled trials
SYSTEMATIC REVIEW
30 September 2024
The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors: an updated systematic review of randomized controlled trials
Gyu Yeong Choiand Philip C. Calder
Cardiovascular disease remains a major global health concern. The combination of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) has been shown to beneficially modify a range of cardiovascular risk factors. However, whether EPA and DHA have differential effects or potencies is currently unclear. A systematic review of randomised controlled trials (RCTs) that compared > 2 g/day of near pure EPA and DHA was conducted. A total of 24 publications from 9 unique RCTs were included. EPA and DHA both lower triglyceride levels, with DHA most likely having a slightly greater effect. Furthermore, both EPA and DHA increase high density lipoprotein (HDL) 2 cholesterol, which is cardioprotective, with the increase being greater with DHA. DHA appears to increase low density lipoprotein (LDL) cholesterol; however, DHA also increases LDL particle size, which would render LDL less atherogenic. DHA seems more effective than EPA in decreasing heart rate and blood pressure. Both EPA and DHA alter platelet function decreasing thrombogenicity, although they may have different actions on platelets. Both EPA and DHA decrease F2-isoprostanes, interpreted as a reduction in oxidative stress. They both decrease inflammatory gene expression and promote an anti-inflammatory oxylipin profile. These are all favourable effects with regard to cardiovascular disease risk. Effects of EPA and DHA on blood glucose are inconsistent. This review is constrained by the small number of high quality RCTs that directly compare EPA to DHA and report on outcomes other than blood lipids. There is a need for additional high-quality research to assess the independent effects of EPA and DHA on cardiovascular risk factors (e.g. inflammation, blood pressure, vascular function, platelet function) in larger and more diverse study populations.

16,883 views

40 citations

Associations of ω-3, ω-6 polyunsaturated fatty acids intake and ω-6: ω-3 ratio with systemic immune and inflammatory biomarkers: NHANES 1999-2020
ORIGINAL RESEARCH
7 June 2024
Associations of ω-3, ω-6 polyunsaturated fatty acids intake and ω-6: ω-3 ratio with systemic immune and inflammatory biomarkers: NHANES 1999-2020
Yifan Li, 8 more and Wei Ji
Background: In recent years, diseases caused by abnormal immune-inflammatory responses have become increasingly severe. Dietary intervention involving omega-3 polyunsaturated fatty acids (ω-3 PUFAs) has emerged as a potential treatment. However, research investigating the relationship between ω-3, ω-6 PUFAs, and ω-6 to ω-3 ratio with inflammatory biomarkers remains controversial. Methods: To investigate the correlation between the intake of ω-3 and ω-6 PUFAs and the ratio of ω-6: ω-3 with biomarkers of inflammation, the National Health and Nutrition Examination Survey (NHANES) data (1999 to 2020) was utilized. The systemic immune-inflammation index (SII), platelet-lymphocyte ratio (PLR), neutrophil-lymphocyte ratio (NLR), and white blood cell (WBC) were selected as study subjects. Dietary data for ω-3 and ω-6 PUFAs were collected via two 24-hour dietary recall interviews. SII index and other indicators were obtained from the blood routine data. The multiple linear regression and restricted cubic spline models were utilized to evaluate the association of ω-3, ω-6 PUFAs intake, and ω-6: ω-3 ratio to SII and secondary measures. Results: This study involved a total of 43,155 American adults. ω-3 and ω-6 PUFAs exhibited negative correlations with SII, PLR, NLR, and WBC. The correlation between ω-6: ω-3 ratio and SII, PLR, NLR, and WBC was not significant. Furthermore, the dose-response relationship showed that the relationship between the intake of ω-3 and ω-6 PUFAs and SII was an "L" pattern. Conclusion: Intake of dietary ω-3 and ω-6 PUFAs reduces the levels of several inflammatory biomarkers in the body and exerts immunomodulatory effects.

7,288 views

27 citations

ORIGINAL RESEARCH
3 July 2024
Effect of FADS1 SNPs rs174546, rs174547 and rs174550 on blood fatty acid profiles and plasma free oxylipins
Miriam Rabehl, 8 more and Anne Pietzner

5,549 views

8 citations

ORIGINAL RESEARCH
9 May 2024
The relationship between dietary intake of ω-3 and ω-6 fatty acids and frailty risk in middle-aged and elderly individuals: a cross-sectional study from NHANES
Zhaoqi Yan, 3 more and Liangji Liu

4,938 views

17 citations

ORIGINAL RESEARCH
12 February 2024
Mussel oil is superior to fish oil in preventing atherosclerosis of ApoE−/− mice
Kelei Li, 5 more and Duo Li

5,170 views

9 citations

REVIEW
2 February 2024
Optimal omegas – barriers and novel methods to narrow omega-3 gaps. A narrative review
Emma J. Derbyshire, 4 more and Weili Li

7,105 views

19 citations

CLINICAL TRIAL
25 January 2024
Effectiveness of omega-3 fatty acid supplementation for pruritus in patients undergoing hemodialysis
Alireza Rafieipoor, 11 more and Maryam Gholamalizadeh

4,511 views

10 citations

ORIGINAL RESEARCH
24 January 2024
The supplementation of a high dose of fish oil during pregnancy and lactation led to an elevation in Mfsd2a expression without any changes in docosahexaenoic acid levels in the retina of healthy 2-month-old mouse offspring
Irena Jovanovic Macura, 5 more and Sanja Ivkovic

6,849 views

3 citations